Bibliografisk träff 2021-10-15 BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate. Cherney RJ, Anjanappa P, Selvakumar K, Batt DG, Brown GD, Rose AV, Vuppugalla R, Chen J, Pang J, Xu S, Yarde M, Tebben AJ, Paidi VR, Cvijic ME, Mathur A, Barrish JC, Mandlekar S, Zhao Q, Carter PH. ACS Med Chem Lett · rapid-communication; journal article · DOI 10.1021/acsmedchemlett.1c00373